Bioprocessing

Biological hydrogen generation is often considered economically unfeasible because of the high costs associated with synthetic growth media and feedstocks. Despite this, the global push for a decarbonized energy grid has turned hydrogen into a critical focal point, primarily because its energy

The future of regenerative medicine may depend on refining extraction processes to preserve higher-molecular-weight proteins within hybrid keratin-based systems. As the medical community faces an escalating global shortage of donor organs and tissues, the search for sustainable, bioactive

Establishing mathematical models for population growth highlights how plant-based supplements can match the theoretical carrying capacity of full-serum media. As we navigate the bioprocessing landscape of 2026, the reliance on animal-derived components like fetal bovine serum and newborn calf serum

Vertex Pharmaceuticals says its commercial team is ready for povetacicept, a prospective treatment for IgA nephropathy that could receive Food and Drug Administration approval by the end of the month. That readiness brings the company’s kidney strategy closer to patient care, where the eventual

The complexity of molecular transformations in pharmaceutical synthesis demands enzymes that maintain high selectivity without sacrificing the speed of the chemical reaction. These biological catalysts are the foundation of many life-sustaining processes, yet their natural forms are rarely suited

By mimicking the natural bone extracellular matrix, these composite scaffolds address the physiological limitations of existing synthetic materials used in orthopedic surgery. The global healthcare landscape is currently navigating a quiet but profound crisis as bone-related injuries and